Administrative Guidance against Ministry of Health, Labour and Welfare

厚生労働省 (Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices)
Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical DevicesMinistry of Health, Labour and WelfareNovember 27, 2017

Action summary

Company
Original: 厚生労働省
Corporate Number: 6000012070001
Governing law
Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices
薬機法
Action type
Administrative Guidance
行政指導
Action date
November 27, 2017
Issuing authority
Ministry of Health, Labour and Welfare
厚生労働省

Violation

Machine-translated summary — verify against original

Regardless of the type or use of anti-influenza virus drugs, at least during the first two days of treatment, children and minors should not be left alone. For residents in high-rise buildings, ensure that all entrances and windows are securely locked, have children sleep in rooms not facing the balcony, sleep in rooms with window grilles, and, in the case of detached houses, sleep on the first floor as much as possible.

Show original Japanese text

抗インフルエンザウイルス薬の種類や服用の有無にかかわらず、少なくとも治療開始後2日間は小児・未成年者を一人にしないことや、高層階の住居の場合は玄関や全ての部屋の窓の施錠を確実に行う、ベランダに面していない部屋で寝かせる、窓に格子のある部屋で寝かせる、一戸建ての場合はできる限り1階で寝かせるといった対策を示した

Source

Original Ministry of Health, Labour and Welfare announcement (in Japanese)

The original Japanese disclosure is the authoritative record.

Watch this company

Get an email when Ministry of Health, Labour and Welfare has new enforcement actions or registry changes (representative, address, business status). Sign-in is via a one-time email link — no password.

Company info

English name
Ministry of Health, Labour and Welfare Official
Japanese name
厚生労働省
Corporate Number
6000012070001
Registered address
東京都千代田区霞が関1丁目2-2
See company profile →

About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.